https://www.selleckchem.com/products/blebbistatin.html Synchrotron-based X-ray absorption spectroscopy and scattering are known in situ probes of metal nanoparticles (NPs). A limited number of laboratory techniques allow post-synthesis diagnostics of the active metal surface area. This work demonstrates the high potential of infrared spectroscopy as an in situ laboratory probe for the growth of metal NPs on a substrate. We introduce a small fraction of CO molecules into the reaction mixture as a probe to monitor the reduction kinetics of the Pd2+ precursor on ceria in hydrogen.The unprecedented development of prostate cancer therapy is a challenge for the proper sequential use of modern medicines. Patients' life expectancies improve when we use treatment lines, one after the other. There is no evidence- based guideline regarding the optimal sequence, but a number of data are available to help the physician selecting the best individualized therapeutic option. The basic treatment for advanced prostate cancer is still androgenic deprivation (ADT), to which we can add additional therapeutic agents. New types of hormonal (androgen receptor targeted, ARTA) agents are being used in an increasingly early line. Chemotherapy (CT) is the first choice in case of metastatic, hormone-sensitive disease especially in high volume cases that are causing symptoms or visceral crisis. CT is otherwise applied after ARTA. We have little but encouraging data about the early, sequential use of ARTAs with different mechanisms of action. In later lines, cross-resistance may develop between ARTA treatments, in which cases CT is the right decision. In this paper, we summarize the results of clinical trials that may help in therapeutic decision making, maximizing the benefits for patients.Lung cancer is known for its outstanding incidence and mortality rates. One of the cornerstones of the treatment of this disease is radiation therapy. A remarkable development was observed in this field throug